Clinical Trial Update: Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms [Phase 2]

View source ↗

Summary

Phase 2 study evaluating RAD1901 for vasomotor symptoms in postmenopausal women was terminated; results were posted but no further development noted in the prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms

Drugs mentioned

• RAD1901

Snippet

Sponsor: Radius Pharmaceuticals, Inc. | Conditions: Vasomotor Symptoms, Hot Flashes | Phase 2 | Status: TERMINATED | Results posted: 2019-03-13